Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
by
Ishima, Tamaki
, Nagai, Ryozo
, Aizawa, Kenichi
, Osaka, Hitoshi
in
Amyotrophic lateral sclerosis
/ Antioxidants
/ Apomorphine
/ apomorphine derivatives
/ Axonogenesis
/ Cell death
/ Communication
/ Cytotoxicity
/ Disease
/ Dopamine D3 receptors
/ Dopamine D5 receptors
/ edaravone
/ Ferroptosis
/ Fibroblasts
/ Nerve growth factor
/ neurite outgrowth
/ Neurodegenerative diseases
/ Neuroplasticity
/ Neuroprotection
/ Nrf2 activation
/ Oxidative stress
/ Parkinson's disease
/ Pediatrics
/ Penicillin
/ Pheochromocytoma cells
/ siRNA
/ Statistical analysis
/ therapeutic agents
/ Therapeutic applications
/ Variance analysis
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
by
Ishima, Tamaki
, Nagai, Ryozo
, Aizawa, Kenichi
, Osaka, Hitoshi
in
Amyotrophic lateral sclerosis
/ Antioxidants
/ Apomorphine
/ apomorphine derivatives
/ Axonogenesis
/ Cell death
/ Communication
/ Cytotoxicity
/ Disease
/ Dopamine D3 receptors
/ Dopamine D5 receptors
/ edaravone
/ Ferroptosis
/ Fibroblasts
/ Nerve growth factor
/ neurite outgrowth
/ Neurodegenerative diseases
/ Neuroplasticity
/ Neuroprotection
/ Nrf2 activation
/ Oxidative stress
/ Parkinson's disease
/ Pediatrics
/ Penicillin
/ Pheochromocytoma cells
/ siRNA
/ Statistical analysis
/ therapeutic agents
/ Therapeutic applications
/ Variance analysis
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
by
Ishima, Tamaki
, Nagai, Ryozo
, Aizawa, Kenichi
, Osaka, Hitoshi
in
Amyotrophic lateral sclerosis
/ Antioxidants
/ Apomorphine
/ apomorphine derivatives
/ Axonogenesis
/ Cell death
/ Communication
/ Cytotoxicity
/ Disease
/ Dopamine D3 receptors
/ Dopamine D5 receptors
/ edaravone
/ Ferroptosis
/ Fibroblasts
/ Nerve growth factor
/ neurite outgrowth
/ Neurodegenerative diseases
/ Neuroplasticity
/ Neuroprotection
/ Nrf2 activation
/ Oxidative stress
/ Parkinson's disease
/ Pediatrics
/ Penicillin
/ Pheochromocytoma cells
/ siRNA
/ Statistical analysis
/ therapeutic agents
/ Therapeutic applications
/ Variance analysis
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
Journal Article
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Apomorphine (APO), a dopamine agonist, activates nuclear factor erythroid 2-related factor 2 (Nrf2) and exerts antioxidant effects, making it a promising candidate for neuroprotection against oxidative stress. This study evaluated neuroplasticity-enhancing properties of newly synthesized APO derivatives, focusing on their ability to promote neurite outgrowth in PC12 cells under nerve growth factor (NGF) stimulation. D55, an APO derivative, retains the hydroxyl group at APO’s 11th position while substituting the 10th with an ethoxy group. D55 exhibited the highest potency (EC50 = 0.5661 nM), significantly enhancing neurite outgrowth. APO demonstrated the highest efficacy (Emax ~10-fold increase), while edaravone (Eda) required higher concentrations (EC50 = 22.5 nM) for moderate effects (Emax ~4-fold increase). D30, in which the 11th hydroxyl was replaced with a methoxy group, had no effect. Neurite outgrowth-promoting effects of APO, D55, and Eda were significantly attenuated by Nrf2 siRNA knockdown, confirming that their neuroplasticity effects are Nrf2-mediated. These findings confirm that D55 is a highly potent Nrf2-activating compound with strong neuroprotective potential, providing new insights into its therapeutic applications for neurodegenerative diseases associated with oxidative stress.
This website uses cookies to ensure you get the best experience on our website.